Yahoo奇摩 網頁搜尋

搜尋結果

  1. Supplement. eAppendix 1. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017: Background, Methods and Evidence Summaries eAppendix 2. Centers for Disease Control and Prevention Guideline for the Prevention

    • Sandra I. Berríos-Torres, Craig A. Umscheid, Dale W. Bratzler, Brian Leas, Erin C. Stone, Rachel R. ...
    • 2017
  2. Importance Gallbladder disease affects approximately 20 million people in the US. Acute cholecystitis is diagnosed in approximately 200 000 people in the US each year. Observations Gallstone-associated cystic duct obstruction is responsible for 90% to 95% of the cases of acute cholecystitis. ...

  3. 1 天前 · Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform. Research Letter. online first. Ransomware Attacks, ED Visits and Inpatient Admissions in Targeted and Nearby Hospitals online first. Opinion. Tirzepatide for Obesity Treatment online firstfree access.

    • 一直放屁原因1
    • 一直放屁原因2
    • 一直放屁原因3
    • 一直放屁原因4
  4. Angioedema is swelling caused by fluid leakage from blood vessels into the surrounding skin and tissue. Angioedema can involve any part of the body but is usually more pronounced around the eyes, lips, mouth, tongue, extremities, and genitalia.

  5. Major findings suggest that: chemosensory dysfunction influences quality of life; complaints of taste loss usually reflect loss of smell function; upper respiratory infection, head trauma, and chronic nasal and paranasal sinus disease are the most common causes of the diminution of the sense of smell, with head trauma having the greatest loss; d...

  6. A PubMed search was performed for the period between January 1, 2010, and January 25, 2021, for studies of the diagnosis and treatment of headache, migraine, TTH, cluster headache, and secondary headache disorders in adults. Clinical trials, systematic reviews, guidelines, and medical society position papers were prioritized.

  7. 2016年11月15日 · This Recommendation Statement from the US Preventive Services Task Force recommends use of low- to moderate-dose statins for primary prevention in adults aged 40 to 75 years who have 1 or more CVD risk factors and a calculated CVD event risk of 10% or greater (B recommendation).

  1. 其他人也搜尋了